Cargando…
Effect of valaciclovir on CD4 count decline in untreated HIV: an international randomized controlled trial
OBJECTIVES: To determine the impact of valaciclovir on HIV disease progression in treatment-naive HIV-positive adults. METHODS: In this fully blind, multicentre, 1:1 randomized placebo-controlled trial, treatment-naive HIV-1-positive adults with CD4 counts 400–900 cells/mm(3) and not meeting contemp...
Autores principales: | Tan, Darrell H S, Raboud, Janet M, Szadkowski, Leah, Grinsztejn, Beatriz, Madruga, José Valdez, Figueroa, Maria Ines, Cahn, Pedro, Barton, Simon E, Clarke, Amanda, Fox, Julie, Zubyk, Wendy, Walmsley, Sharon L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337901/ https://www.ncbi.nlm.nih.gov/pubmed/30376108 http://dx.doi.org/10.1093/jac/dky433 |
Ejemplares similares
-
Inflammatory biomarker levels over 48 weeks with dual vs triple lopinavir/ritonavir-based therapy: Substudy of a randomized trial
por: Tan, Darrell H. S., et al.
Publicado: (2019) -
Can herpes simplex virus type 2 suppression slow HIV disease progression: a study protocol for the VALacyclovir In Delaying Antiretroviral Treatment Entry (VALIDATE) trial
por: Tan, Darrell HS, et al.
Publicado: (2010) -
Effect of Intercurrent Infections and Vaccinations on Immune and Inflammatory Biomarkers Among Human Immunodeficiency Virus-Infected Adults on Suppressive Antiretroviral Therapy
por: Tan, Darrell H. S., et al.
Publicado: (2015) -
Zona ophtalmique à localisation palpébrale: bonne évolution sous valaciclovir
por: Benotmane, Fatim-Ezzohra, et al.
Publicado: (2014) -
In vivo and in vitro palatability testing of a new paediatric formulation of valaciclovir
por: Bastiaans, Diane E. T., et al.
Publicado: (2017)